JG
VIVE

Jefferies Group’s VIVEVE MED INC VIVE Stock Holding History

Jefferies Group’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15
Closed -$95K – 2679
2017
Q1 		$95K Buy
+15
New +$73K ﹤0.01% 2138

Other funds holding VIVE

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

Jefferies Group's VIVE Position: Q2 2017 in Review

Jefferies Group sold out of VIVEVE MED INC (VIVE) in Q2 2017, closing a stake of 15 shares — an estimated $95K sold.

Jefferies Group first reported a position in VIVE in Q1 2017 and held it in 1 quarter. The position peaked at $95K in Q1 2017. 46 funds tracked by Wall St. Rank hold VIVE as of Q2 2017.

  • Jefferies Group reported no remaining VIVEVE MED INC position as of Q2 2017 after selling out during the quarter.
  • Jefferies Group sold 15 VIVEVE MED INC shares in Q2 2017, an estimated $95K.
  • Jefferies Group first reported a position in VIVEVE MED INC in Q1 2017 and held it in 1 quarter.
  • Jefferies Group's VIVEVE MED INC position peaked at $95K in Q1 2017.
  • 46 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2017.

Based on Jefferies Group's 13F filing for Q2 2017, filed 14 Aug 2017.